|

Nituzumab/placebo Clinical Trials

1 actively recruiting trial

Also known as: Nituzumab injection (taixinsheng)

Pipeline

Phase 2: 1

Top Sponsors

  • Sichuan Cancer Hospital and Research Institute1

Indications

  • Nasopharyngeal Carcinoma1
  • Cancer1

Other1 trial

Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Clinical Study on the Efficacy and Safety of Combined Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinomatreatment of Locally Advanced Nasopharyngeal Carcinoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.